DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award

Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic leads through U.S.

Amount: Not stated
Type: Grant

Key facts

Key facts for DoW Amyotrophic Lateral Sclerosis Research Program, Therapeutic Development Award
Amount	Not stated
Issuer	Defense Health Agency Contracting Activity - DHACA
Who can apply	US companies
Sectors	Deep tech
Deadline	Closes 30 Sep 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 4 days ago

40 days agoagentImported from the official source

Opportunities with the same funding type or region
AI Growth Lab		Closes 27 Sep 2026
BJA FY 2026 Adult Treatment Court Program	up to $2.5M	Closes 30 Oct 2026
BJA FY 2026 Capital Case Litigation Initiative: Improving the Quality of Legal Representation in State Capital Cases	up to $450,000	Closes 29 Oct 2026